VYNE Therapeutics  logo
VYNE Therapeutics VYNE
$ 0.67 1.84%

Quarterly report 2026-Q1
added 05-15-2026

report update icon

VYNE Therapeutics EV/EBITDA Ratio 2011-2026 | VYNE

Annual EV/EBITDA Ratio VYNE Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.236 -2.13 -0.00723 0.403 -0.407 -2.05 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.403 -2.13 -0.738